Melissa S. DeRycke, Ph.D.
Affiliations: | 2010 | Microbiology, Immunology and Cancer Biology | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
OncologyGoogle:
"Melissa DeRycke"Parents
Sign in to add mentorAmy P. N. Skubitz | grad student | 2010 | UMN | |
(S100A1 and nectin 4 biomarkers in ovarian cancer.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
DeRycke MS, Gunawardena S, Balcom JR, et al. (2017) Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes. Molecular Genetics & Genomic Medicine. 5: 553-569 |
Boylan KLM, Buchanan PC, Shukla D, et al. (2016) Abstract B58: Functional analysis of the cell adhesion molecule Nectin-4 in the unique tumor microenvironment of ovarian cancer. Clinical Cancer Research. 22 |
Derycke MS, Charbonneau B, Preston CC, et al. (2013) Toward understanding the genetics of regulatory T cells in ovarian cancer. Oncoimmunology. 2: e24535 |
Charbonneau B, Goode EL, Kalli KR, et al. (2013) The immune system in the pathogenesis of ovarian cancer. Critical Reviews in Immunology. 33: 137-64 |
Xu J, Lange EM, Lu L, et al. (2013) HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Human Genetics. 132: 5-14 |
Derycke MS, Pambuccian SE, Gilks CB, et al. (2010) Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker. American Journal of Clinical Pathology. 134: 835-45 |
DeRycke MS, Andersen JD, Harrington KM, et al. (2009) S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival. American Journal of Clinical Pathology. 132: 846-56 |
Tchagang AB, Tewfik AH, DeRycke MS, et al. (2008) Early detection of ovarian cancer using group biomarkers. Molecular Cancer Therapeutics. 7: 27-37 |